- about the companyThis leading-edge biotechnology firm is at the forefront of developing next-generation RNAi and siRNA therapeutics. The organization is dedicated to advancing the field of RNA-based medicine through the development of innovative delivery platforms, with a specific focus on extrahepatic targeting and novel AOC/PCC modalities.The Singapore-based early discovery team acts as a vital international hub for the firm's research efforts. This grouabout the companyThis leading-edge biotechnology firm is at the forefront of developing next-generation RNAi and siRNA therapeutics. The organization is dedicated to advancing the field of RNA-based medicine through the development of innovative delivery platforms, with a specific focus on extrahepatic targeting and novel AOC/PCC modalities.The Singapore-based early discovery team acts as a vital international hub for the firm's research efforts. This grou
- about the companyThis innovative biotechnology organization is a leader in the advancement of RNAi and siRNA therapeutics. The firm is committed to developing next-generation RNA-based medicines, prioritizing the creation of sophisticated delivery platforms that enable extrahepatic targeting and utilize novel AOC/POC (Antibody/Peptide-Oligonucleotide Conjugate) modalities.Located in Singapore, the early-discovery group operates as a premier international Rabout the companyThis innovative biotechnology organization is a leader in the advancement of RNAi and siRNA therapeutics. The firm is committed to developing next-generation RNA-based medicines, prioritizing the creation of sophisticated delivery platforms that enable extrahepatic targeting and utilize novel AOC/POC (Antibody/Peptide-Oligonucleotide Conjugate) modalities.Located in Singapore, the early-discovery group operates as a premier international R
